Joel Block to Immunosuppressive Agents
This is a "connection" page, showing publications Joel Block has written about Immunosuppressive Agents.
Connection Strength
1.367
-
Corticosteroid Monotherapy Is Usually Insufficient Treatment for Idiopathic Inflammatory Myopathy. Am J Ther. 2015 Sep-Oct; 22(5):350-4.
Score: 0.473
-
Tuberculosis infections and tumor necrosis factor alpha antagonists. Am J Ther. 2013 Jan; 20(1):73-8.
Score: 0.394
-
Efficacy of low-dose versus high-dose cyclophosphamide in lupus nephritis: comment on the article by Houssiau et al. Arthritis Rheum. 2003 May; 48(5):1466; author reply 1466-7.
Score: 0.201
-
Retrospective Study of Patients on Etanercept Therapy for Rheumatic Diseases in Patients With Chronic Hepatitis C Virus. J Clin Rheumatol. 2017 Aug; 23(5):252-257.
Score: 0.135
-
The treatment of psoriatic arthritis. Am J Ther. 2006 Jan-Feb; 13(1):72-9.
Score: 0.061
-
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis. 2004 Aug 01; 39(3):295-9.
Score: 0.055
-
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Arthritis Rheum. 2002 Aug; 46(8):2020-8.
Score: 0.048